Break-through Clinical Trials

A drug is designated as a breakthrough clinical trial if it addresses a serious or life-threatening condition and preliminary clinical evidence suggests that it may show significant improvement over current therapies on a clinically relevant endpoint(s).

We are devoted to finding new ways to help treat, mitigate or cure diseases.